High risk of severe anaemia after chlorproguanil-dapsone+artesunate antimalarial treatment in patients with G6PD (A-) deficiency

CI Fanello, C Karema, P Avellino, G Bancone, A Uwimana, SJ Lee, Umberto D'Alessandro, D Modiano

    Research output: Contribution to journalA1: Web of Science-article

    Original languageEnglish
    JournalPLoS ONE
    Volume3
    Issue number12
    Pages (from-to)e4031
    ISSN1932-6203
    DOIs
    Publication statusPublished - 2008

    Keywords

    • B780-tropical-medicine
    • Antimalarials
    • Artemisinin combination therapies (ACT)
    • Dapsone
    • Adverse effects
    • Hemolysis
    • Anemia
    • Risk groups
    • G6PD deficiency
    • Clinical trials
    • Rwanda
    • Africa-Central

    Cite this